Investors

With our unique and established capabilities and strategy for growth, we offer a clear proposition to investors.

Find out how our business model, strategy and established capabilities support our clear investment proposition.

Find out how we are performing in our Annual Report.

Investor calendar

18 May 2018

Interim Management Statement (May)

15 August 2018

8 November 2018

Interim Management Statement

News feed from the London Stock Exchange's Regulatory News Service.

25 April 2018

Block listing Interim Review

24 April 2018

Hikma expands licensing agreement with Rovi

20 April 2018

Hikma launches Dexrazoxane for Injection

Information on the high standards of governance we’re committed to, our governance structure, Board, key committees, and remuneration policy.

Historical summary of our financial results and key performance indicators.